General Information of Drug (ID: DM30P2H)

Drug Name
MRKAd5/ALVAC
Indication
Disease Entry ICD 11 Status REF
Human immunodeficiency virus infection 1C62 Phase 1 [1]
Cross-matching ID
TTD ID
D0R5GF

References

1 ClinicalTrials.gov (NCT00894114) A Study of Safety, Tolerability and Immunogenicity of a 1-Dose Regimen of MRKAd5 HIV-1 Gag Vaccine Versus the ALVAC_HIV Vaccine (V520-019). U.S. National Institutes of Health.